Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.85% vs 3.82% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.96% vs 9.06% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 67.27% vs -26.24% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 23.42% vs 5.57% in Mar 2024
Compare Profit and Loss Results of Jenburkt Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
151.00
181.00
-30.00
-16.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
151.00
181.00
-30.00
-16.57%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
29.00
93.00
-64.00
-68.82%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
45.00
10.00
35.00
350.00%
Operating Expenses
4.00
5.00
-1.00
-20.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
14.00
31.00
-17.00
-54.84%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
111.00
150.00
-39.00
-26.00%
Operating Profit (PBDIT) excl Other Income
40.00
31.00
9.00
29.03%
Other Income
6.00
13.00
-7.00
-53.85%
Operating Profit (PBDIT)
47.00
44.00
3.00
6.82%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
46.00
42.00
4.00
9.52%
Depreciation
2.00
1.00
1.00
100.00%
Profit Before Taxation & Exceptional Items
43.00
40.00
3.00
7.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
43.00
40.00
3.00
7.50%
Provision for Tax
11.00
9.00
2.00
22.22%
Profit After Tax
32.00
31.00
1.00
3.23%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
134.00
131.00
3.00
2.29%
Profit Available for appropriations
166.00
162.00
4.00
2.47%
Appropriations
166.00
162.00
4.00
2.47%
Equity Dividend (%)
180%
0%
180.00
Earnings Per Share
72.65
19.37
53.28
275.06%
Profit And Loss - Net Sales
Net Sales 151.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.85% vs 3.82% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.39 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.96% vs 9.06% in Mar 2024
Profit And Loss - Interest
Interest 0.45 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 67.27% vs -26.24% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 32.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.42% vs 5.57% in Mar 2024
